Episodio – Bevacizumab, VEGF y dehiscencia de heridas | USMLE Step 1 episode artwork

EPISODE · Jan 23, 2026 · 6 MIN

Episodio – Bevacizumab, VEGF y dehiscencia de heridas | USMLE Step 1

from USMLE DREAMERS · host USMLE DREAMERS

En este episodio analizamos un caso de dehiscencia de herida secundaria al uso de bevacizumab, un anticuerpo monoclonal anti-VEGF. Revisamos las fases de cicatrización, el papel crítico de la angiogénesis mediada por VEGF y por qué su inhibición produce fracaso tardío del cierre de heridas.#USMLEDreamers #USMLEStep1 #Pathology #Pharmacology #WoundHealing #Bevacizumab #VEGF #Angiogenesis #IMG #Step1Español

Episode metadata supplied by the publisher feed · Published Jan 23, 2026

Embed this episode

NOW PLAYING

Episodio – Bevacizumab, VEGF y dehiscencia de heridas | USMLE Step 1

0:00 6:48

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of USMLE DREAMERS?

This episode is 6 minutes long.

When was this USMLE DREAMERS episode published?

This episode was published on January 23, 2026.

Can I download this USMLE DREAMERS episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!